FIELD: medicine; biotechnology.
SUBSTANCE: described is the use of a tincture of common sage leaves, obtained on ethyl alcohol with concentration of 30-70%, but with the exception of concentrations of 31.5% and 50%, and in a raw material : extractant ratio of 1:5, as an antifungal agent against Aspergillus fumigatus, Aspergillus flavus, Aspergillus niger for the treatment and prevention of fungal infections on the oral mucosa and pharynx.
EFFECT: invention enables to use sage tincture for treating and preventing fungal infections caused by Aspergillus fumigatus, Aspergillus flavus, Aspergillus niger, on oral mucosa and pharynx.
1 cl, 4 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF SAGE TINCTURE AS ANTIFUNGAL AGENT AGAINST SCOPULARIOPSIS BREVICAULIS | 2024 |
|
RU2835714C1 |
| USE OF SAGE TINCTURE AS ANTIFUNGAL AGENT AGAINST MUCOR MUCEDO | 2024 |
|
RU2835171C1 |
| ANTIBACTERIAL HAND SPRAY | 2022 |
|
RU2811227C1 |
| DEVELOPMENT OF ANTIFUNGAL OINTMENT BASED ON SALVIN | 2019 |
|
RU2698201C1 |
| METHOD OF PRODUCING AN ANTIFIBIC ANTIBACTERIAL EMERICILLIPSIN A | 2019 |
|
RU2710377C1 |
| AGENT FOR PREVENTION AND TREATMENT OF PERIODONTAL DISEASES AND TEETH AND MOUTH CARE | 2014 |
|
RU2624518C2 |
| VEGETAL ORIGIN AGENT IN FORM OF LIQUID EXTRACT HAVING ANTIFUNGAL ACTIVITY | 2019 |
|
RU2734247C2 |
| STREPTOMYCES HYGROSCOPICUS 18 STRAIN - NAPHTHOQUINONE ANTIBIOTICS PRODUCER - A AND B ASTOLIDES WITH ANTIFUFGAL AND CYTOTOXIC ACTIVITY AND METHOD FOR PRODUCING THEREOF | 2018 |
|
RU2681828C1 |
| AGENT HAVING ABILITY TO INHIBIT GROWTH OF CANDIDA ALBICANS AND STAPHYLOCOCCUS AUREUS | 2024 |
|
RU2836892C1 |
| MEDICINE FOR PREVENTION AND TREATMENT OF ANDROGENETIC ALOPECIA, ALOPECIA SEBORRHEICA AND AREATA, SEBORRHEA ADIPOSA AND CONCRETE SEBORRHEA OF SCALP, SCURF, AND METHOD FOR OBTAINING SAME | 2006 |
|
RU2333763C2 |
